¼¼°èÀÇ È¯ÀÚ Âü¿© ºÐ¾ß ÀΰøÁö´É ½ÃÀå
Artificial Intelligence in Patient Engagement
»óǰÄÚµå : 1643510
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 248 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,502,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 25,507,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ȯÀÚ Âü¿© ºÐ¾ß ÀΰøÁö´É ¼¼°è ½ÃÀå, 2030³â±îÁö 231¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 80¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ȯÀÚ Âü¿© ºÐ¾ß ÀΰøÁö´É ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 19.4%ÀÇ CAGR·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 231¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀΠŬ¶ó¿ìµå ±â¹Ý Àü¼Û ¸ðµå ºÎ¹®Àº CAGR 21.7%¸¦ ±â·ÏÇÏ¿© ºÐ¼® ±â°£ Á¾·á ½ÃÁ¡¿¡ 184¾ï ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿ÂÇÁ·¹¹Ì½º Á¦°ø ¸ðµå ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 12.8%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 21¾ï ´Þ·¯, Áß±¹Àº CAGR 18.3%·Î ¼ºÀå Àü¸Á

¹Ì±¹ÀÇ È¯ÀÚ Âü¿© ÀΰøÁö´É ½ÃÀå ±Ô¸ð´Â 2024³â 21¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 35¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2024-2030³â ºÐ¼® ±â°£ µ¿¾È 18.3%ÀÇ CAGR(¿¬Æò±Õ 18.3%)À» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ µ¿¾È °¢°¢ 18.0%¿Í 16.4%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ ¾à 13.0%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è ȯÀÚ Âü¿© ÀΰøÁö´É ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ Á¤¸®

AI°¡ ȯÀÚ Âü¿©¸¦ ¾î¶»°Ô º¯È­½Ãų °ÍÀΰ¡?

ÀΰøÁö´É(AI)Àº °³ÀÎÈ­µÈ Ä¡·á¸¦ Á¦°øÇϰí, Ä¿¹Â´ÏÄÉÀ̼ÇÀ» °³¼±Çϸç, ȯÀÚ°¡ ÀÚ½ÅÀÇ °Ç°­ °ü¸®¿¡ Àû±ØÀûÀÎ ¿ªÇÒÀ» ÇÒ ¼ö ÀÖµµ·ÏÇÔÀ¸·Î½á ȯÀÚ Âü¿©¿¡ Çõ¸íÀ» ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. ±âÁ¸ÀÇ È¯ÀÚ Âü¿© ¹æ½ÄÀº ¼öÀÛ¾÷°ú Ç¥ÁØÈ­µÈ Á¢±Ù ¹æ½Ä¿¡ ÀÇÁ¸ÇÏ´Â °æ¿ì°¡ ¸¹¾Æ ȯÀÚ °³°³ÀÎÀÇ ´ÏÁî¿¡ È¿°úÀûÀ¸·Î ´ëÀÀÇÏÁö ¸øÇßÁö¸¸, AI´Â ¸Ó½Å·¯´×(ML), ÀÚ¿¬¾î ó¸®(NLP), ¿¹Ãø ºÐ¼®À» Ȱ¿ëÇÏ¿© ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇϰí, ¸ÂÃãÇüÀÇ ÀÇ¹Ì Àִ ȯÀÚ °æÇèÀ» Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. ¸ÂÃãÇüÀÇ ÀÇ¹Ì Àִ ȯÀÚ °æÇèÀ» ½ÇÇöÇÕ´Ï´Ù.

AI ±â¹Ý 꺿°ú °¡»ó ºñ¼­´Â 24½Ã°£ 365ÀÏ 24½Ã°£ Áö¿øÀ» Á¦°øÇϰí, ȯÀÚ ¹®ÀÇ¿¡ ´ëÇÑ ´äº¯, ¿¹¾à ¿¹¾à, Åõ¾à ¾Ë¸²À» º¸³»ÁÖ´Â µî ´Ù¾çÇÑ ±â´ÉÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â ÀÇ·á ¼­ºñ½º Á¦°øÀÚÀÇ °ü¸® ºÎ´ãÀ» ÁÙÀ̸鼭 Á¢±Ù¼ºÀ» Çâ»ó½Ãŵ´Ï´Ù. ¶ÇÇÑ, AI ½Ã½ºÅÛÀº ȯÀÚ µ¥ÀÌÅ͸¦ ºÐ¼®ÇÏ¿© °³ÀÎÈ­µÈ °Ç°­ Á¦¾ÈÀ» Á¦°øÇÔÀ¸·Î½á Âü¿© Àü·«ÀÌ °³ÀÎÀÇ ÃëÇâ°ú º´·Â¿¡ ºÎÇÕÇÏ´ÂÁö¸¦ È®ÀÎÇÒ ¼ö ÀÖ½À´Ï´Ù.

¶ÇÇÑ AI´Â ¸ð¹ÙÀÏ ¾Û, Æ÷ÅÐ, ¿þ¾î·¯ºí ±â±â¸¦ ÅëÇØ ¸ÂÃãÇü ÄÁÅÙÃ÷¸¦ Á¦°øÇÔÀ¸·Î½á ȯÀÚ ±³À°À» °­È­ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Ç÷§ÆûÀº °Ç°­ »óÅÂ, Ä¡·á ¿É¼Ç, »ýȰ½À°ü º¯È­¿¡ ´ëÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÏ¿© Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. AI´Â Áö¼ÓÀûÀÌ°í ¸Æ¶ô¿¡ ¸Â´Â Âü¿©¸¦ °¡´ÉÇϰÔÇÔÀ¸·Î½á ȯÀÚ¿Í ÀÇ·á ¼­ºñ½º¿ÍÀÇ °ü°è ¹æ½ÄÀ» º¯È­½Ã۰í ÀÖ½À´Ï´Ù.

ȯÀÚ Âü¿©¿¡ ÀÖ¾î AI µµÀÔÀÇ ¿øµ¿·ÂÀº ¹«¾ùÀΰ¡?

°³ÀÎÈ­µÇ°í È¿À²ÀûÀÎ ÇコÄÉ¾î °æÇè¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϸ鼭 ȯÀÚ Âü¿©¿¡ AI¸¦ µµÀÔÇÏ´Â µ¥ Å« ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ȯÀÚµéÀÌ ÀÚ½ÅÀÇ Çʿ信 ¸Â´Â ¸ÂÃãÇü Ä¡·á¸¦ ¿øÇÏ´Â °æÇâÀÌ ³ô¾ÆÁü¿¡ µû¶ó, AI ±â¹Ý ¼Ö·ç¼ÇÀº ȯÀÚ ¸¸Á·µµ¿Í Ä¡·á °á°ú¸¦ Çâ»ó½ÃŰ´Â ¸ÂÃãÇü Ä¿¹Â´ÏÄÉÀ̼ǰú Áö¿øÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â µðÁöÅп¡ Àͼ÷ÇÑ È¯ÀÚºÎÅÍ ´õ ¸¹Àº ¾È³»¸¦ ÇÊ¿ä·Î Çϴ ȯÀÚ±îÁö ´Ù¾çÇÑ È¯ÀÚ ¼±È£µµ¸¦ ÃæÁ·½Ãų ¼ö ÀÖ½À´Ï´Ù.

¿ø°ÝÀÇ·á ¹× ¿ø°ÝÁø·á ¸ðµ¨ÀÇ ºÎ»óµµ AI µµÀÔ¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. °¡»ó Áø·á°¡ º¸ÆíÈ­µÇ¸é¼­ AI ±â¹Ý Ç÷§ÆûÀº ȯÀڵ鿡°Ô ÀÚ°¡ ¸ð´ÏÅ͸µ, Áõ»ó ÃßÀû, °¡»ó ÈÄ¼Ó Á¶Ä¡¸¦ À§ÇÑ µµ±¸¸¦ Á¦°øÇÔÀ¸·Î½á ±× °ÝÂ÷¸¦ ¸Þ¿ì°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â´ÉÀ» ÅëÇØ ¿ø°ÝÁö³ª ÀÇ·á ¼­ºñ½º°¡ ºÎÁ·ÇÑ Áö¿ªÀÇ È¯ÀÚµéÀÇ Á¢±Ù¼ºÀ» Çâ»ó½ÃŰ¸é¼­ Ä¡·áÀÇ ¿¬¼Ó¼ºÀ» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

¶ÇÇÑ, µ¥ÀÌÅÍ ÅëÇÕ°ú »óÈ£¿î¿ë¼ºÀÇ ¹ßÀüÀ¸·Î AI ½Ã½ºÅÛÀº ¿©·¯ Á¢Á¡¿¡¼­ ¿øÈ°ÇÑ È¯ÀÚ Âü¿©¸¦ Á¦°øÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. EHR, ¿þ¾î·¯ºí ±â±â, °Ç°­ ¾ÛÀÇ µ¥ÀÌÅ͸¦ ºÐ¼®ÇÔÀ¸·Î½á AI´Â ȯÀÚÀÇ ÆäÀ̼¾Æ® ¿©Á¤À» ÅëÇÕÀûÀ¸·Î ÆÄ¾ÇÇÏ¿© ÀϰüµÇ°í ¿µÇâ·Â ÀÖ´Â »óÈ£ ÀÛ¿ëÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ȯÀÚ Âü¿© Àü·«À» À籸ÃàÇÏ´Â µ¥ ÀÖ¾î AIÀÇ Á߿伺ÀÌ Ä¿Áö°í ÀÖÀ½À» º¸¿©ÁÝ´Ï´Ù.

AI°¡ °Ç°­ °á°ú¿Í ȯÀÚ ¸¸Á·µµ¸¦ ³ôÀÏ ¼ö ÀÖÀ»±î?

AI´Â »çÀü ¿¹¹æÀûÀÌ°í °³ÀÎÈ­µÈ Ä¡·á¸¦ ÃËÁøÇÏ¿© °Ç°­ °á°ú¿Í ȯÀÚ ¸¸Á·µµ¸¦ Å©°Ô Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ¿¹Ãø ºÐ¼® µµ±¸´Â ¸¸¼ºÁúȯ ¹× ÇÕº´Áõ À§ÇèÀÌ Àִ ȯÀÚ¸¦ ½Äº°ÇÏ¿© Àû½Ã¿¡ °³ÀÔÇϰí ÀÔ¿ø °¡´É¼ºÀ» ³·Ãâ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ¿¹¸¦ µé¾î, AI ½Ã½ºÅÛÀº Ȱ·Â ¡ÈÄ¿Í »ýȰ½À°ü µ¥ÀÌÅ͸¦ ¸ð´ÏÅ͸µÇÏ°í ´ç´¢º´À̳ª ½ÉÀ庴°ú °°Àº Áúº´ÀÇ Á¶±â °æ°í ½ÅÈ£¸¦ °¨ÁöÇÏ¿© ÀÇ·á ¼­ºñ½º Á¦°øÀÚ°¡ ¿¹¹æ Á¶Ä¡¸¦ ÃëÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.

AI´Â ÀÏ»óÀûÀÎ ¾÷¹«¸¦ ÀÚµ¿È­Çϰí Áø·á Á¶Á¤À» °³¼±ÇÔÀ¸·Î½á Á¾Á¾ ȯÀÚÀÇ ºÒ¸¸À» ¾ß±âÇÏ´Â °ü¸®»óÀÇ ºñÈ¿À²¼ºÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ½Ç½Ã°£ ¾÷µ¥ÀÌÆ®, ÀÚµ¿ ¿¹¾à ¾Ë¸², ÀÇ·á Á¤º¸¿¡ ´ëÇÑ ¼Õ½¬¿î ¾×¼¼½º¸¦ ÅëÇØ ȯÀÚ´Â Ç×»ó Á¤º¸¸¦ ¾ò°í Ä¡·á¿¡ Âü¿©ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â´ÉÀº ȯÀÚÀÇ Àü¹ÝÀûÀÎ °æÇèÀ» °³¼±Çϰí Ä¡·á °èȹÀÇ ¼øÀÀµµ¸¦ ³ôÀÔ´Ï´Ù.

AI´Â ¶ÇÇÑ ½ºÆ®·¹½º °ü¸®, ¸¶À½Ã¬±è, Çൿ Ä¡·á¸¦ À§ÇÑ µµ±¸¸¦ Á¦°øÇÔÀ¸·Î½á Á¤½Å°Ç°­°ú À£ºùÀ» Áö¿øÇÒ ¼ö ÀÖ½À´Ï´Ù. °¡»ó ºñ¼­´Â ȯÀÚ Ä¡·áÀÇ Á¤¼­Àû Ãø¸é¿¡ ´ëÀÀÇÏ°í °³ÀÎÈ­µÈ Ãßõ°ú ´ëó Àü·«À» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ÀüÀÎÀû °Ç°­ °ü¸®¿¡ ±â¿©ÇÏ°í ½ÅüÀû, Á¤½ÅÀû À£ºùÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.

ȯÀÚ Âü¿© AI ½ÃÀåÀÇ ¼ºÀå ¿øµ¿·ÂÀº ¹«¾ùÀΰ¡?

ȯÀÚ Âü¿© ºÐ¾ß ÀΰøÁö´É(AI) ½ÃÀå ¼ºÀåÀº ÇコÄÉ¾î ºÐ¾ßÀÇ Çõ½Å °¡´É¼ºÀ» ¹Ý¿µÇÏ´Â ¸î °¡Áö Áß¿äÇÑ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ȯÀÚ Á᫐ Áø·á ¸ðµ¨¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ÀÇ·á ¼­ºñ½º Á¦°øÀÚµéÀº Ä¿¹Â´ÏÄÉÀ̼ÇÀ» °³¼±ÇÏ°í °³ÀÎÈ­µÈ °æÇèÀ» Á¦°øÇϱâ À§ÇØ AI µµ±¸¸¦ µµÀÔÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀº Á¶Á÷ÀÌ È¯ÀÚ¿ÍÀÇ °ü°è¸¦ °­È­Çϰí Ãæ¼ºµµ¿Í ½Å·Úµµ¸¦ ³ôÀÌ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

¸Ó½Å·¯´×, NLP, ½Ç½Ã°£ ºÐ¼®°ú °°Àº AI ±â¼ú ¹ßÀüÀº ȯÀÚ Âü¿© Ç÷§ÆûÀÇ ±â´ÉÀ» È®ÀåÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â ÀÇ·á ¼­ºñ½º Á¦°øÀÚ°¡ ȯÀÚÀÇ ¿ä±¸¸¦ ¿¹ÃøÇÏ°í »çÀü ¿¹¹æÀû Áö¿øÀ» Á¦°øÇÒ ¼ö ÀÖ´Â ½Ç¿ëÀûÀÎ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.

µðÁöÅÐ °Ç°­ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö´Â µî ¼ÒºñÀÚ Çൿ Æ®·»µå°¡ ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ȯÀÚµéÀº ¸ð¹ÙÀÏ ¾Û, ¿þ¾î·¯ºí ±â±â, °¡»ó ºñ¼­¸¦ °Ç°­ °ü¸®¸¦ À§ÇÑ È¿°úÀûÀÎ µµ±¸·Î ¹Þ¾ÆµéÀ̰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °¡Ä¡ ±â¹Ý ÀÇ·á ¹× È¯ÀÚ Âü¿© ÀÌ´Ï¼ÅÆ¼ºê¸¦ ÃËÁøÇÏ´Â ±ÔÁ¦Àû Àμ¾Æ¼ºê°¡ ÇコÄÉ¾î ºÐ¾ß¿¡¼­ÀÇ AI äÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ÀÌ·¯ÇÑ ¿äÀεéÀº µðÁöÅÐ Çコ ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡¿Í ÇÔ²² ȯÀÚ Âü¿©¿¡ ´ëÇÑ AI ½ÃÀåÀÇ ±Þ¼ÓÇÑ È®ÀåÀ» ÃËÁøÇϰí ÀÖÀ¸¸ç, ÀÇ·á Á¦°ø ¹× ȯÀÚ Á᫐ ¼­ºñ½ºÀÇ ¹Ì·¡ Çõ½ÅÀÇ Ãʼ®À¸·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦°ø ÇüÅÂ(Ŭ¶ó¿ìµå ±â¹Ý Á¦°ø ÇüÅÂ, ¿ÂÇÁ·¹¹Ì½º Á¦°ø ÇüÅÂ), ±â´É(Ä¿¹Â´ÏÄÉÀÌ¼Ç °­È­ ±â´É, 꺿 & °¡»ó °Ç°­ µµ¿ì¹Ì ±â´É, ¿¹Ãø ºÐ¼® ±â´É, ȯÀÚ ±³À° ±â´É, ±âŸ ±â´É), ±â¼ú(ÀÚ¿¬¾î ó¸®(NLP) ±â¼ú, ±âŸ ±â¼ú), Ä¡·á ¿µ¿ª(¸¸¼ºÁúȯ °ü¸® Ä¡·á ¿µ¿ª, °Ç°­ ¹× À£´Ï½º Ä¡·á ¿µ¿ª, ±âŸ Ä¡·á ¿µ¿ª), ÃÖÁ¾»ç¿ëÀÚ(ÀÇ·á °ø±ÞÀÚ ÃÖÁ¾»ç¿ëÀÚ, ÀÇ·á ÁöºÒÀÚ ÃÖÁ¾»ç¿ëÀÚ, ±âŸ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê(ÁÖ¸ñ 52°³»ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Artificial Intelligence in Patient Engagement Market to Reach US$23.1 Billion by 2030

The global market for Artificial Intelligence in Patient Engagement estimated at US$8.0 Billion in the year 2024, is expected to reach US$23.1 Billion by 2030, growing at a CAGR of 19.4% over the analysis period 2024-2030. Cloud-based Delivery Mode, one of the segments analyzed in the report, is expected to record a 21.7% CAGR and reach US$18.4 Billion by the end of the analysis period. Growth in the On-Premise Delivery Mode segment is estimated at 12.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.1 Billion While China is Forecast to Grow at 18.3% CAGR

The Artificial Intelligence in Patient Engagement market in the U.S. is estimated at US$2.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.5 Billion by the year 2030 trailing a CAGR of 18.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 18.0% and 16.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.0% CAGR.

Global Artificial Intelligence in Patient Engagement Market - Key Trends & Drivers Summarized

How Is AI Transforming Patient Engagement?

Artificial Intelligence (AI) is revolutionizing patient engagement by delivering personalized care, improving communication, and empowering patients to take an active role in their health management. Traditional patient engagement methods often rely on manual interactions and standardized approaches that fail to address individual needs effectively. AI addresses these challenges by leveraging machine learning (ML), natural language processing (NLP), and predictive analytics to create tailored and meaningful patient experiences.

AI-powered chatbots and virtual assistants provide 24/7 support, answering patient queries, scheduling appointments, and sending medication reminders. These tools enhance accessibility while reducing the administrative burden on healthcare providers. In addition, AI systems analyze patient data to offer personalized health recommendations, ensuring that engagement strategies align with individual preferences and medical histories.

Moreover, AI enhances patient education by delivering customized content through mobile apps, portals, and wearable devices. These platforms provide insights into health conditions, treatment options, and lifestyle changes, fostering informed decision-making. By enabling continuous and context-aware engagement, AI is transforming the way patients interact with healthcare services.

What Drives the Adoption of AI in Patient Engagement?

The growing demand for personalized and efficient healthcare experiences is a major driver of AI adoption in patient engagement. As patients increasingly seek customized care that addresses their unique needs, AI-powered solutions offer tailored communication and support that enhances satisfaction and outcomes. These tools cater to diverse patient preferences, from digital-savvy individuals to those requiring more guidance.

The rise of telemedicine and remote care models is also fueling AI adoption. With virtual consultations becoming more prevalent, AI-driven platforms bridge the gap by providing patients with tools for self-monitoring, symptom tracking, and virtual follow-ups. These capabilities ensure continuity of care while improving access for patients in remote or underserved areas.

Additionally, advancements in data integration and interoperability are enabling AI systems to provide seamless patient engagement across multiple touchpoints. By analyzing data from electronic health records (EHRs), wearable devices, and health apps, AI creates a unified view of the patient journey, ensuring consistent and impactful interactions. These trends underscore the growing importance of AI in reshaping patient engagement strategies.

Can AI Enhance Health Outcomes and Patient Satisfaction?

AI is significantly enhancing health outcomes and patient satisfaction by fostering proactive and personalized care. Predictive analytics tools identify patients at risk of chronic conditions or complications, enabling timely interventions and reducing the likelihood of hospitalizations. For example, AI systems monitor vital signs and lifestyle data to detect early warning signs of conditions such as diabetes or heart disease, allowing healthcare providers to take preventive action.

By automating routine tasks and improving care coordination, AI reduces administrative inefficiencies that often lead to patient dissatisfaction. Real-time updates, automated appointment reminders, and easy access to medical information empower patients to stay informed and engaged in their care. These capabilities enhance the overall patient experience while ensuring better adherence to treatment plans.

AI also supports mental health and well-being by providing tools for stress management, mindfulness, and behavioral therapy. Virtual mental health assistants deliver personalized recommendations and coping strategies, addressing the emotional aspects of patient care. These innovations contribute to holistic health management, improving both physical and mental well-being.

What’s Driving the Growth of the AI in Patient Engagement Market?

The growth in the Artificial Intelligence in Patient Engagement market is driven by several critical factors, reflecting its transformative potential in healthcare. The increasing focus on patient-centric care models is encouraging healthcare providers to adopt AI tools that improve communication and deliver personalized experiences. These solutions help organizations build stronger relationships with patients, enhancing loyalty and trust.

Technological advancements in AI, including machine learning, NLP, and real-time analytics, are expanding the capabilities of patient engagement platforms. These tools provide actionable insights that enable healthcare providers to anticipate patient needs and deliver proactive support.

Consumer behavior trends, such as the growing preference for digital health solutions, are further driving market growth. Patients are embracing mobile apps, wearable devices, and virtual assistants as tools to manage their health effectively. Additionally, regulatory incentives promoting value-based care and patient engagement initiatives are supporting the adoption of AI in healthcare.

These factors, coupled with increasing investments in digital health technologies, are propelling the rapid expansion of the AI in Patient Engagement market, positioning it as a cornerstone of future innovation in healthcare delivery and patient-centric services.

SCOPE OF STUDY:

The report analyzes the Artificial Intelligence in Patient Engagement market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Delivery Mode (Cloud-based Delivery Mode, On-Premise Delivery Mode); Functionality (Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality, Other Functionalities); Technology (Natural Language Processing (NLP) Technology, Other Technologies); Therapeutic Area (Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area, Other Therapeutic Areas); End-Use (Healthcare Providers End-Use, Healthcare Payers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 52 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â